Matthew Giust

2.5k citations
4 papers · 1.6k · 2 hit papers · h-index 2

Impact in

  • Ophthalmology top 0.2%
    • Retinal Diseases and Treatments
    • Retinal and Optic Conditions
    • Glaucoma and retinal disorders
    • Retinal Imaging and Analysis
    • Retinal and Macular Surgery
    • Corneal Surgery and Treatments
    • Retinopathy of Prematurity Studies

Papers in

    • Retinal Diseases and Treatments 4
    • Glaucoma and retinal disorders 1
    • Retinal and Optic Conditions 1
    • Cerebral Venous Sinus Thrombosis 1

Matthew Giust

3 papers receiving 1.6k citations

Matthew Giust's Hit Papers

Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy 2006 · 645 citations
6450+6+13Years since publication250500750

Peers

Matthew Giust
Comparison fields: 5 of 53
  • Ophthalmology 1.2k
  • Radiology, Nuclear Medicine and Imaging 588
  • Molecular Biology 191
  • Clinical Biochemistry 16
  • Neurology 14
Replace Mauro Goldbaum with:
Mauro Goldbaum United States
Albrecht Lommatzsch Germany
Alexandre Sellam France
Ellen C. La Heij Netherlands
Soraya Rofagha United States
Christoph Ehlken Germany
Tsuyoshi Otsuji Japan
Wataru Matsumiya Japan
R J Antcliff United Kingdom
Hossein Nazari United States
Matthew Giust relative to Mauro Goldbaum United States Mauro Goldbaum's profile →
Citations per field
00.5×1.5×
Mauro Goldbaum · 1×
Citations per year

Countries citing papers authored by Matthew Giust

Since Specialization
Citations

This map shows the geographic impact of Matthew Giust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Giust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Giust more than expected).

Fields of papers citing papers by Matthew Giust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Giust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Giust. The network helps show where Matthew Giust may publish in the future.

Co-authors

The 8 scholars most cited alongside Matthew Giust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Giust Line = papers co-authored together Matthew Giust links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Hit paper breakdown →
2006985
2
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
Hit paper breakdown →
2006645
3
Intravitreal Bevacizumab (Avastin®) in the Surgical Treatment of Proliferative Diabetic Retinopathy
20071
4 20070

About Matthew Giust

Matthew Giust is a scholar working on Ophthalmology, Neurology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 1.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (4 papers), Glaucoma and retinal disorders (1 paper), Retinal and Optic Conditions (1 paper), Retinal and Macular Surgery (1 paper) and Cerebral Venous Sinus Thrombosis (1 paper). The work is most often cited by research in Ophthalmology (1.2k citations), Radiology, Nuclear Medicine and Imaging (588 citations), Molecular Biology (191 citations), Clinical Biochemistry (16 citations) and Neurology (14 citations). Matthew Giust has collaborated with scholars based in United States. Frequent co-authors include Melvin Rabena, Alessandro Castellarin, Ma'an Nasir, Dante J. Pieramici, Robert L. Avery, Joel Pearlman, Robert Wendel and Arun Patel. Their work appears in journals such as Ophthalmology and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact